Overview
Calcium glycerophosphate is a Calcium salt of glycerophosphoric acid that forms a white, fine, slightly hygroscopic powder. The commercial product is a mixture of calcium beta-, and D-, and L -alpha-glycerophosphate. By FDA, calcium glycerophosphate is considered a generally recognized as safe (GRAS) food ingredient as a nutrient supplement (source of calcium or phosphorus), or in food products such as gelatins, puddings, and fillings. It is also present in dental or oral hygiene products due to its cariostatic effects. It is suggested that calcium glycerophosphate promotes plaque-pH buffering, elevation of plaque Calcium and phosphate levels and direct interaction with dental mineral .
Indication
Calcium glycerophosphate is found in OTC dental products such as toothpastes for the prevention of dental caries. As OTC products these do not have an official indication. In prescription products it is indicated as a Calcium or phosphate donor for replacement or supplementation in patients with insufficient Calcium or phosphate.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2009/04/03 | Phase 1 | Completed | Federal University of Paraíba |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| ElementAll Diet | 447331 | Medicine | A | 5/1/2024 | |
| ElementAll Diet Vanilla Coconut | 427642 | Medicine | A | 11/9/2023 | |
| OXYMIN CALM HIGHLY ABSORBABLE EFFERVESCENT CALCIUM & MAGNESIUM COMPLEX | 79737 | Z & C Krpan | Medicine | A | 8/2/2001 |
| HYDROCAL | 100428 | Medicine | A | 3/29/2004 | |
| UM Calm | 367065 | Medicine | A | 5/25/2021 | |
| ElementAll Diet | 319772 | Medicine | A | 7/5/2019 | |
| ElementAll Diet Tropical | 329196 | Medicine | A | 1/28/2020 | |
| ElementAll Diet Tropical | 447332 | Medicine | A | 5/1/2024 | |
| NOVA PLUS NEW LIFE oral liquid suspension bottle | 47206 | Nova Sante Pacific (International) Pty Ltd | Medicine | A | 11/25/1993 |
| UM Calm | 305381 | Medicine | A | 6/27/2018 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| FORMULA 22158 | therapeutic foods co. | 00191531 | Capsule - Oral | 161 MG / CAP | 5/18/1994 |
| HEMAREXIN LIQ | lab bio chimique inc.,division of technilab pharma inc. | 01922742 | Liquid - Oral | 12.5 MG / 5 ML | 12/22/1993 |
| GLYCOBAL FORTIS | lab nadeau ltée, division of technilab inc. | 00250635 | Liquid - Oral | 8 MG / ML | 12/31/1951 |
| BETACOL | therapeutic foods co. | 00191388 | Capsule - Oral | 50 MG | 12/15/1989 |
| CALCIUM INJ | kripps pharmacy ltd. | 00532762 | Liquid - Intramuscular
,
Intravenous
,
Subcutaneous | 10 MG / ML | 12/31/1981 |
| TRIOGENE FOR | produits francais labs inc. | 00166219 | Powder - Oral | 549.25 MG / 30 G | 12/31/1930 |
| GLYCOBAL ENFANT | lab nadeau ltée, division of technilab inc. | 00146056 | Liquid - Oral | 7.5 MG / ML | 12/31/1951 |
| FORMULE 37805 | therapeutic foods co. | 00241571 | Capsule - Oral | 22 MG / CAP | 12/31/1951 |
| HEMO SOMATON | desbergers ltée, division of technilab inc. | 00342394 | Tablet
,
Liquid - Oral | 120 MG / TAB | 12/31/1951 |
| HEMO SOMATON C | desbergers ltée, division of technilab inc. | 00342408 | Liquid
,
Tablet - Oral | 120 MG / TAB | 12/31/1951 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.